These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 17508300

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N, Dávila J, Oliveros A, Castillo J, Medrano JJ.
    Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of functional MRI markers in mild cognitive impairment.
    Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y.
    J Clin Neurosci; 2009 May; 16(5):635-41. PubMed ID: 19264490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2009 May; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 11. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kölsch H, Kornhuber J, Träber F.
    Neurology; 2009 May 19; 72(20):1735-40. PubMed ID: 19451528
    [Abstract] [Full Text] [Related]

  • 12. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio.
    Okada T, Sakamoto S, Nakamoto Y, Kohara N, Senda M.
    Psychiatry Res; 2007 Nov 15; 156(2):169-74. PubMed ID: 17900878
    [Abstract] [Full Text] [Related]

  • 13. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR, den Hollander JA, Stewart CC, Evanochko WT, Buchthal SD, Harrell LE, Zamrini EY, Brockington JC, Marson DC.
    NMR Biomed; 2007 Dec 15; 20(8):709-16. PubMed ID: 17295394
    [Abstract] [Full Text] [Related]

  • 14. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T, Shiino A, Akiguchi I.
    Dement Geriatr Cogn Disord; 2008 Dec 15; 26(1):89-100. PubMed ID: 18617735
    [Abstract] [Full Text] [Related]

  • 15. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B, Chen KM, Ling HW, Zhang H, Chai WM, Li X, Wang T.
    Dement Geriatr Cogn Disord; 2008 Dec 15; 25(3):218-25. PubMed ID: 18219201
    [Abstract] [Full Text] [Related]

  • 16. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.
    J Alzheimers Dis; 2011 Dec 15; 27(3):591-601. PubMed ID: 21841260
    [Abstract] [Full Text] [Related]

  • 17. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ.
    Acta Radiol; 2008 Jun 15; 49(5):602-10. PubMed ID: 18568549
    [Abstract] [Full Text] [Related]

  • 18. [Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?].
    Hentschel F, Kreis M, Damian M, Krumm B.
    Rofo; 2004 Dec 15; 176(12):1743-9. PubMed ID: 15573284
    [Abstract] [Full Text] [Related]

  • 19. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 20. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J.
    Neurol Res; 2010 Mar 15; 32(2):157-65. PubMed ID: 20158954
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.